Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The integrated multiomic diagnosis of sporadic meningiomas: a review of its clinical implications
Stephanie M. Robert, Shaurey Vetsa, Arushii Nadar, et al.
Journal of Neuro-Oncology (2021) Vol. 156, Iss. 2, pp. 205-214
Open Access | Times Cited: 23

Showing 23 citing articles:

Pathology of the Tumors of the Central Nervous System
Redi Bumci, Ioannis Parthymos, Constantinos Zamboglou, et al.
Springer eBooks (2023), pp. 71-110
Closed Access | Times Cited: 22
Surgical strategies for intracranial meningioma in the molecular era
Alper Dincer, Saul F. Morales-Valero, Stephanie M. Robert, et al.
Journal of Neuro-Oncology (2023) Vol. 162, Iss. 2, pp. 253-265
Open Access | Times Cited: 16
Diarylpentanoid, a curcumin analog, inhibits malignant meningioma growth in both in vitro and in vivo models
Akihiro Terasawa, Kazuhiro Shimazu, Hiroshi Nanjo, et al.
World Journal of Experimental Medicine (2025) Vol. 15, Iss. 2
Closed Access
The multiomic landscape of meningiomas: a review and update
Justin Z. Wang, Farshad Nassiri, Alexander Landry, et al.
Journal of Neuro-Oncology (2023) Vol. 161, Iss. 2, pp. 405-414
Open Access | Times Cited: 10
The Evolving Classification of Meningiomas: Integration of Molecular Discoveries to Inform Patient Care
S. Joy Trybula, Mark W. Youngblood, Constantine L. Karras, et al.
Cancers (2024) Vol. 16, Iss. 9, pp. 1753-1753
Open Access | Times Cited: 2
Unveiling a Biomarker Signature of Meningioma: The Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5339-5339
Open Access | Times Cited: 5
Brain Invasion and Trends in Molecular Research on Meningioma
Kyeong-O Go, Young Zoon Kim
Brain Tumor Research and Treatment (2023) Vol. 11, Iss. 1, pp. 47-47
Open Access | Times Cited: 4
Sulforaphane suppresses cell proliferation and induces apoptosis in glioma via the ACTL6A/PGK1 axis
Zi-tan Peng, Rong Hu, Jing-yu Fu
Toxicology Mechanisms and Methods (2024) Vol. 34, Iss. 5, pp. 507-516
Closed Access | Times Cited: 1
Meningioma recurrence: Time for an online prediction tool?
Abdulrahman Albakr, Amir Baghdadi, Brij Karmur, et al.
Surgical Neurology International (2024) Vol. 15, pp. 155-155
Open Access | Times Cited: 1
Exploring machine learning applications in Meningioma Research (2004–2023)
Liwei Zhong, Kun‐Shan Chen, Hua-Biao Yang, et al.
Heliyon (2024) Vol. 10, Iss. 12, pp. e32596-e32596
Open Access | Times Cited: 1
LncRNA-IMAT1 Promotes Invasion of Meningiomas by Suppressing KLF4/hsa-miR22-3p/Snai1 Pathway
Yaodong Ding, Yu Ge, Daijun Wang, et al.
Molecules and Cells (2022) Vol. 45, Iss. 6, pp. 388-402
Open Access | Times Cited: 7
Molecular determinants of outcomes in meningiomas
John Lynes, Gabriel Flores-Milán, Sebastian Rubino, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 7
Unveiling a Biomarker Signature of Meningioma: the Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
(2023)
Open Access | Times Cited: 2
Epigenetic biomarkers in personalized medicine
Andrea Stoccoro, Fabio Coppedè, Lucia Migliore
Elsevier eBooks (2024), pp. 147-194
Closed Access
Methylation profiling in the contemporary management of meningioma
Alexander Landry, Leeor S. Yefet, Justin Z. Wang, et al.
Journal of Neuro-Oncology (2024)
Closed Access
Petrous and Clival Meningiomas
Nicola Boari, Francesco Calvanese, Mariagrazia Nizzola, et al.
(2024), pp. 159-182
Closed Access
[A two-site combined prediction model based on HOXA9 DNA methylation for early screening of risks of meningioma progression].
Rui Zhen Tan, Xiuliang Bao, Liang Han, et al.
PubMed (2024) Vol. 44, Iss. 11, pp. 2110-2120
Closed Access
Susceptibility-Weighted MRI for Predicting NF-2 Mutations and S100 Protein Expression in Meningiomas
Sena Azamat, Buse Buz-Yalug, Sukru Samet Dindar, et al.
Diagnostics (2024) Vol. 14, Iss. 7, pp. 748-748
Open Access
Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas
Paulina Kober, Beata Joanna Mossakowska, Natalia Rusetska, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13483-13483
Open Access | Times Cited: 1
Unveiling a Biomarker Signature of Meningioma: the Need for a Panel of Genomic, Epigenetic, Proteomic, and RNA Biomarkers to Advance Diagnosis and Prognosis
Reem Halabi, Fatima Dakroub, Mohammad Z. Haider, et al.
(2023)
Open Access | Times Cited: 1
AhR and HIF-1α Signaling Pathways in Benign Meningioma under Hypoxia
M. L. Perepechaeva, Lyubov S. Klyushova, A. Yu. Grishanova
International Journal of Cell Biology (2023) Vol. 2023, pp. 1-10
Open Access
Intratumoral heterogeneity of meningioma with respect of the methylation profiling
П.В. Никитин, Guzel R. Musina, В.Н. Полозов, et al.
Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» (2023) Vol. 67, Iss. 1, pp. 124-132
Open Access
Susceptibility-Weighted MRI for Predicting NF-2 Mutation and S100 Protein Expression in Meningiomas
Sena Azamat, Buse Buz-Yaluğ, Sukru Samet Dindar, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top